Okanishi Tohru, Fujimori Ikuo, Yamada Mariko, Tajima Takumi, Wataya-Kaneda Mari, Seyama Kuniaki, Hatano Takashi
Division of Child Neurology, Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago, Japan.
Novartis Pharma K.K, 1-23-1 Toranomon, Minato-ku, Tokyo, 105-6333, Japan.
Orphanet J Rare Dis. 2024 Dec 1;19(1):451. doi: 10.1186/s13023-024-03460-y.
Tuberous sclerosis complex (TSC) is a rare autosomal dominant genetic disorder that affects multiple organs. However, precise diagnosis is challenging owing to the lack of truly pathognomonic symptoms. This retrospective observational study aimed to explore the real-world diagnostic flow of Japanese patients with TSC by examining time to diagnosis (TTD) from the onset of each TSC-related manifestation to TSC diagnosis and the role of TSC clinic in timely diagnosis, using data from a health insurance database.
Analyses were performed using data derived from the JMDC Claims Database between January 2005 and December 2020. Patients with at least 1 confirmed diagnosis of TSC were stratified into 2 cohorts: Cohort 1 included cases diagnosed after 2 years of age, and Cohort 2 included cases diagnosed before 2 years of age. The primary endpoint was TTD in Cohorts 1 and 2. Secondary endpoints were the incidence of each manifestation in Cohort 1 and the incidence and risk ratios of TSC-unrelated symptoms in Cohort 2.
Cohorts 1 and 2 included 106 and 42 patients, respectively. In Cohort 1, patients with a renal tumor diagnosis as a primary TSC-related manifestation had the longest TTD with a wide range (median: 23 months to up to 91 months); patients with non-specific TSC-related manifestations such as brain tumor/intraventricular tumor, epilepsy, or intellectual disabilities also experienced a delay in TTD. In patients with TSC who developed epilepsy, those attending facilities with a TSC clinic were diagnosed with TSC more quickly than those attending facilities without a TSC clinic (median: 11.5 and 19.0 months, respectively; p = 0.0379). Epilepsy was the manifestation with the highest incidence (29.2%) among Cohort 1 patients, while cardiac rhabdomyoma had the highest incidence (54.8%) among Cohort 2 patients. Dry skin was the most common TSC-unrelated symptom in Cohort 2, with a 1.7-fold higher incidence rate than that in controls (N = 619,936).
Japanese patients with renal lesions as a primary TSC-related manifestation had the longest delay for a definitive diagnosis of TSC, followed by those with epilepsy, brain tumor/intraventricular tumor, and intellectual disabilities. The TSC clinic played an important role in the early diagnosis of TSC.
结节性硬化症(TSC)是一种罕见的常染色体显性遗传病,可累及多个器官。然而,由于缺乏真正具有诊断特异性的症状,精确诊断具有挑战性。这项回顾性观察性研究旨在通过检查从每种TSC相关表现出现到TSC诊断的诊断时间(TTD)以及TSC诊所及时诊断中的作用,利用健康保险数据库的数据,探索日本TSC患者的真实诊断流程。
使用2005年1月至2020年12月期间从JMDC索赔数据库获得的数据进行分析。至少有1次TSC确诊诊断的患者被分为2个队列:队列1包括2岁以后诊断的病例,队列2包括2岁以前诊断的病例。主要终点是队列1和队列2中的TTD。次要终点是队列1中每种表现的发生率以及队列2中TSC无关症状的发生率和风险比。
队列1和队列2分别包括106例和42例患者。在队列1中,以肾肿瘤诊断作为主要TSC相关表现的患者TTD最长,范围广泛(中位数:23个月至91个月);有非特异性TSC相关表现如脑肿瘤/脑室内肿瘤、癫痫或智力残疾的患者TTD也有延迟。在患有癫痫的TSC患者中,就诊于设有TSC诊所的医疗机构的患者比就诊于没有TSC诊所的医疗机构的患者被诊断为TSC的速度更快(中位数分别为11.5个月和19.0个月;p = 0.0379)。癫痫是队列1患者中发生率最高的表现(29.2%),而心脏横纹肌瘤在队列2患者中发生率最高(54.8%)。皮肤干燥是队列2中最常见的TSC无关症状,其发生率比对照组(N = 619,936)高1.7倍。
以肾脏病变作为主要TSC相关表现的日本患者确诊TSC的延迟时间最长,其次是患有癫痫、脑肿瘤/脑室内肿瘤和智力残疾的患者。TSC诊所在TSC的早期诊断中发挥了重要作用。